Viral Vectors for Gene Delivery and Expression in the CNS.
Publication Type | Academic Article |
Authors | Kaplitt M, Pfaff D |
Journal | Methods |
Volume | 10 |
Issue | 3 |
Pagination | 343-50 |
Date Published | 12/01/1996 |
ISSN | 1095-9130 |
Abstract | Viral vectors have emerged as an important tool for manipulating gene expression in the adult mammalian brain. The adult brain is composed largely of nondividing cells, and therefore DNA viruses have become the vehicle of choice for neurobiologists interested in somatic gene transfer. Recombinant viral vectors based upon adenovirus or herpes simplex virus have been created in which a gene essential for viral replication is removed and a gene of interest is inserted in the viral genome. While this eliminates pathogenicity due to viral replication, retention of viral genes and continued expression of these genes may limit the potential of the current generation of vectors. Defective viral vectors represent a different approach, in which only viral recognition signals are used to allow packaging of foreign DNA into a viral coat while eliminating the possibility of viral gene expression within target cells. The defective HSV vector has been used to transfer genes into the adult rat brain. This vector has also been used for analysis of the preproenkephalin promoter in vivo, and important regions of this promoter have been identified using this technique. A modification of in situ PCR has been developed as an adjunctive tool for sensitively documenting the presence of vector DNA within target cells during in vivo promoter studies. Finally, the adenoassociated virus vector has been used as the first fully defective DNA viral vector, which also eliminates any contamination by helper viruses. This vector can transfer genes into the mammalian brain and has shown significant behavioral recovery in a rodent model of Parkinson's disease. Future work will undoubtedly result in still more diverse and improved vectors; however, these studies have documented the importance of viral vectors to both basic neurobiology and the potential treatment of neurologic disease. |
DOI | 10.1006/meth.1996.0112 |
PubMed ID | 8954846 |